Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Medical technology & services

Goodbody Health launches health 'MOT' to test for diabetes and cholesterol risk

Priced at £99, the tests are designed to determine a person's risk for developing cardiac health problems or diabetes over the next 10 years

Goodbody Health Inc (AQSE:GBDY, CSE:GBDY, OTC:SCNNF) said it is launching a health ‘MOT’ test to be offered at its UK high street stores and via pharmacies, where customers will get results of diabetes and cholesterol tests “in minutes”.

Priced at £99, the company said the innovative tests determine a person's risk for developing cardiac health problems or diabetes over the next 10 years.

The offer will be trialled in a limited number of pharmacies and its own stores in Bath and Bristol, Goodbody said, before being rolled out to its nationwide distribution network of local pharmacies, supported by marketing materials and other activities to drive traffic and increase footfall.

The health check is being launched to coincide with Type 2 Diabetes prevention week, which is designed to highlight that one in 15 people in the UK has diabetes and around a million people who have type 2 diabetes have not yet been diagnosed.

Executive chairman Geremy Thomas said: "We are very excited about the launch of the MOT product. The recent pandemic has made us all realise that our health is our most important asset, there has never been a better time to take control of your current health.

“With a number of clinics already on board and the testing available using new, innovative technology, our developing network will soon be able to offer the MOT as an additional product within their pharmacy.”

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK